Pharmacy

Fast-Track Approval for New Melanoma Combination Treatment

PHILADELPHIA — Accelerated approval has been granted by the Food and Drug Administration to a combination therapy for unresectable or metastatic melanoma with a specific mutation. Approval was announced of a trametinib-dabrafenib combination for use in the treatment of patients… Read More

FDA Reviewing Low-T Therapy After Second Study Shows CV Issues

WASHINGTON — With a second study showing increased risk of cardiovascular events among men using testosterone replacement therapy, the Food and Drug Administration announced that it is reassessing the safety of those products. The agency said it is investigating the… Read More

Controversy Surrounds FDA Approval of New Opioid Analgesic

SAN DIEGO — The Food and Drug Administration has approved a new opioid analgesic but not without controversy. In approving Zohydro ER (hydrocodone bitartrate extended-release capsules), the FDA went against an 11-2 recommendation by a panel of outside experts to… Read More

FDA Allows Marketing of First Device for Migraine Headache Pain

SUNNYVALE, CA — For the first time, the Food and Drug Administration is allowing marketing of a device to relieve pain caused by migraine headaches that are preceded by an aura. The device, the Cerena Transcranial Magnetic Stimulator (TMS), is… Read More

New SGLT2 Inhibitor Approved to Treat Type 2 Diabetes

WASHINGTON — A new sodium-glucose co-transporter 2 (SGLT2) inhibitor has been approved to treat type 2 diabetes. The Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults. Farxiga is marketed… Read More

VA, Army Clinicians Rapidly Increase Prescribing of Novel Anticoagulants

VA, Army Clinicians Rapidly Increase Prescribing of Novel Anticoagulants

WASHINGTON — Use of novel anticoagulants has risen sharply both at the VA and in the Army in the last three years, freeing more atrial fibrillation patients from food restrictions and regular checks for coagulation time, as required when using warfarin.

Pharmacist Monitoring Increases Veteran Adherence to ACS Therapy

Pharmacist Monitoring Increases Veteran Adherence to ACS Therapy

DENVER — Personalized attention from a pharmacist increases medication adherence in patients to nearly 90% in the year following hospitalization for acute coronary syndrome (ACS), according to a recent study.